HMGCR and coronary artery disorder: Similarly, the promoter regions of the GALNT2 gene and HMGCR gene are hypermethylated in a higher percentage of the CHD patients than the non-CHD subjects (54.1% vs. 27.8% and 34.1% vs. 22.2% respectively).